Certain Systems, Devices, Software, Compositions, Chemicals, and Laboratory Supplies for Studying Proteins; Inv. No. 337-TA-1508 (Violation)

This supplemental complaint filing in Inv. No. 337-TA-1508, brought by Seer, Inc. and The Brigham and Women's Hospital, Inc., consists only of appendix exhibits: a protein corona patent specification and USPTO records for U.S. Patent No. 12,228,566. The text supplied contains no complaint narrative, asserted claims, or accused-product allegations. The excerpt shows the technology is a nanoparticle protein corona sensor array with machine learning for early cancer detection. It does not describe the accused products, respondents, or relief. Respondents are listed as unknown, and no exclusion order request appears in the supplied text. Complainants per metadata: Seer, Inc. and The Brigham and Women's Hospital, Inc.; respondents listed as unknown. Appendix material includes the substitute specification for application 18/606,701, titled System and Method for Protein Corona Sensor Array for Early Detection of Diseases. U.S. Patent No. 12,228,566 issued February 18, 2025, and a certificate of correction was signed April 15, 2025. Specification examples describe liposome, silica and polystyrene nanoparticle arrays, random forest classification, and cancer and coronary artery disease detection. No accused products, asserted claims, domestic industry allegations, or requested relief appear in the provided text.